Chip design software firm Synopsys on Wednesday forecast fiscal 2025 revenue below Wall Street expectations thanks in part to a slump in China sales as the U.S. tightens controls on what chip technology can be sold to the country.
Sassine Ghazi, Synopsys CEO, joins 'Closing Bell Overtime' to talk Q4 results, its Ansys acquisition and more.
SNPS' Q4 performance is likely to have reflected the benefits of advanced technology innovations propelled by its strong IP, designs and security solutions.
Beyond analysts' top -and-bottom-line estimates for Synopsys (SNPS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended October 2024.
Zacks.com users have recently been watching Synopsys (SNPS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Synopsys (SNPS) closed the most recent trading day at $523.79, moving +0.58% from the previous trading session.
With slowing growth and rising competition, Synopsys' premium valuation raises concerns. Here's why selling SNPS stock might be wise now.
Loop Capital initiated coverage of Synopsys with a Buy rating and $675 price target. The firm sees increasing captive chip designs coming from system original equipment manufacturers and hyperscalers, and China's chip design activity is outpacing RoW as China attempts to foster a domestic chip industry, the analyst tells investors in a research note. The firm said that this fragmentation in chip design activity presents a long-term secular challenge for traditional merchant semiconductor companies, and investment in companies like Synopsys is an ideal way to hedge against this trend.
Loop Capital analyst Gary Mobley initiated coverage of Synopsys with a Buy rating and $675 price target.
Recently, Zacks.com users have been paying close attention to Synopsys (SNPS). This makes it worthwhile to examine what the stock has in store.
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?